BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17145888)

  • 1. Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptors.
    Chen D; Chan R; Waxman S; Jing Y
    Cancer Res; 2006 Dec; 66(23):11416-23. PubMed ID: 17145888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic inhibitors of extracellular signal-regulated kinase (ERKs) and c-Jun NH(2)-terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia cells to arsenic trioxide-induced apoptosis.
    Ramos AM; Fernandez C; Amrán D; Esteban D; de Blas E; Palacios MA; Aller P
    J Cell Physiol; 2006 Dec; 209(3):1006-15. PubMed ID: 16972261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glutathione synthesis inhibitor enhances arsenic trioxide-induced apoptosis].
    Shen Y; Chen G; Cai X
    Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):259-61. PubMed ID: 11776809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Arsenic trioxide combined with buthionine sulfoximine enhances apoptosis in multidrug-resistant human leukemia K562/ADM cells in vitro].
    Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):188-91. PubMed ID: 18756933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells.
    Davison K; Mann KK; Waxman S; Miller WH
    Blood; 2004 May; 103(9):3496-502. PubMed ID: 14701702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic trioxide sensitizes promonocytic leukemia cells to TNFalpha-induced apoptosis via p38-MAPK-regulated activation of both receptor-mediated and mitochondrial pathways.
    Amrán D; Sánchez Y; Fernández C; Ramos AM; de Blas E; Bréard J; Calle C; Aller P
    Biochim Biophys Acta; 2007 Nov; 1773(11):1653-63. PubMed ID: 17673311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
    Kito M; Akao Y; Ohishi N; Yagi K; Nozawa Y
    Biochem Biophys Res Commun; 2002 Mar; 291(4):861-7. PubMed ID: 11866444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro- and anti-apoptotic roles of c-Jun N-terminal kinase (JNK) in ethanol and acetaldehyde exposed rat hepatocytes.
    Lee YJ; Shukla SD
    Eur J Pharmacol; 2005 Jan; 508(1-3):31-45. PubMed ID: 15680252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation.
    Redondo-Muñoz J; Escobar-Díaz E; Hernández Del Cerro M; Pandiella A; Terol MJ; García-Marco JA; García-Pardo A
    Clin Cancer Res; 2010 Sep; 16(17):4382-91. PubMed ID: 20534739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 12-O-tetradecanoylphorbol-13-acetate may both potentiate and decrease the generation of apoptosis by the antileukemic agent arsenic trioxide in human promonocytic cells. Regulation by extracellular signal-regulated protein kinases and glutathione.
    Fernández C; Ramos AM; Sancho P; Amrán D; de Blas E; Aller P
    J Biol Chem; 2004 Jan; 279(5):3877-84. PubMed ID: 14610070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic apoptosis of CML cells by buthionine sulfoximine and hydroxychavicol correlates with activation of AIF and GSH-ROS-JNK-ERK-iNOS pathway.
    Chowdhury AA; Chaudhuri J; Biswas N; Manna A; Chatterjee S; Mahato SK; Chaudhuri U; Jaisankar P; Bandyopadhyay S
    PLoS One; 2013; 8(9):e73672. PubMed ID: 24040019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines.
    Ramos AM; Aller P
    Biochem Pharmacol; 2008 May; 75(10):1912-23. PubMed ID: 18359480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained activation of c-jun-terminal kinase (JNK) is closely related to arsenic trioxide-induced apoptosis in an acute myeloid leukemia (M2)-derived cell line, NKM-1.
    Kajiguchi T; Yamamoto K; Hossain K; Akhand AA; Nakashima I; Naoe T; Saito H; Emi N
    Leukemia; 2003 Nov; 17(11):2189-95. PubMed ID: 12931215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of arsenic trioxide (As2O3) combined with BSO on K562/ADM cell and its mechanisms].
    Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):438-43. PubMed ID: 18072624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of arsenic trioxide-induced apoptosis by 8-bromo-7-methoxychrysin in human leukemia cells involves depletion of intracellular reduced glutathione.
    Xiao G; Tang X; Yao C; Wang C
    Acta Biochim Biophys Sin (Shanghai); 2011 Sep; 43(9):712-21. PubMed ID: 21785114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway.
    Jing Y; Dai J; Chalmers-Redman RM; Tatton WG; Waxman S
    Blood; 1999 Sep; 94(6):2102-11. PubMed ID: 10477740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system.
    Lösler S; Schlief S; Kneifel C; Thiel E; Schrezenmeier H; Rojewski MT
    Ann Hematol; 2009 Nov; 88(11):1047-58. PubMed ID: 19301004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.
    Kim EH; Yoon MJ; Kim SU; Kwon TK; Sohn S; Choi KS
    Cancer Res; 2008 Jan; 68(1):266-75. PubMed ID: 18172319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.
    Lewis-Wambi JS; Kim HR; Wambi C; Patel R; Pyle JR; Klein-Szanto AJ; Jordan VC
    Breast Cancer Res; 2008; 10(6):R104. PubMed ID: 19061505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of fucoidan-induced apoptosis in leukemic cells: involvement of ERK1/2, JNK, glutathione, and nitric oxide.
    Jin JO; Song MG; Kim YN; Park JI; Kwak JY
    Mol Carcinog; 2010 Aug; 49(8):771-82. PubMed ID: 20572161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.